RxDoctor Payments Data

Nicholas Beechnau, DO

Family Medicine · Ravenna, MINPI 1164784724

Payments from drug & device makers

$1,573in general payments, 2019–2025

Across 111 payments — averaging $14.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$442
  • Pfizer$244
  • Lilly USA, LLC$232
  • Amgen$115
  • GSK$97
  • Novartis$76
  • plus $368 from 11 others

What the payments were for

  • Food & beverage$1,56599%
  • Education$81%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,573 in reported general payments places this provider in the 75th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$16,621
Medicare patients
49
Services billed
283

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban105$81,215
TrulicityDulaglutide44$60,932
Trelegy ElliptaFluticasone/Umeclidin/Vilanter52$32,559
MounjaroTirzepatide17$26,786
JardianceEmpagliflozin19$24,351
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog21$20,281
FarxigaDapagliflozin Propanediol16$11,782
EntrestoSacubitril/Valsartan16$11,465
Stiolto RespimatTiotropium Br/Olodaterol Hcl16$10,749
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr20$8,634
Atorvastatin Calcium217$4,444
Novolog FlexpenInsulin Aspart14$3,800
Albuterol Sulfate HfaAlbuterol Sulfate65$2,656
Omeprazole135$2,610
Levothyroxine Sodium136$2,333

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$232$87,71861 claims
PfizerEliquis$244$81,215105 claims
GSKTrelegy Ellipta, Anoro Ellipta$97$41,19372 claims
Boehringer IngelheimJardiance, Stiolto Respimat$37$35,09935 claims
AstraZenecaFarxiga$39$11,78216 claims
NovartisEntresto$76$11,46516 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Ravenna

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →